XML 31 R46.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingencies (Details) (USD $)
In Millions, except Per Share data, unless otherwise specified
9 Months Ended 12 Months Ended 2 Months Ended 9 Months Ended 12 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended 9 Months Ended 12 Months Ended 3 Months Ended
Jun. 30, 2013
Cash performance unit awards
Sep. 30, 2012
Cash performance unit awards
Sep. 30, 2010
Cash performance unit awards
Sep. 30, 2012
Cash performance unit awards - 2012 grants
Sep. 30, 2011
Cash performance unit awards - 2012 grants
Jun. 30, 2013
Cash performance unit awards - 2012 grants
Sep. 30, 2014
Cash performance unit awards - 2012 grants
Sep. 30, 2013
Cash performance unit awards - 2012 grants
Jun. 30, 2013
Cash performance unit awards - 2013 grants
Jun. 30, 2013
Cash performance unit awards - 2013 grants
Jun. 30, 2013
SARs
Jun. 30, 2012
SARs
Jun. 30, 2013
SARs
Jun. 30, 2012
SARs
Jun. 30, 2013
SARs - 2011 Awards
Sep. 30, 2011
SARs - 2011 Awards
Jun. 30, 2013
SARs - 2012 Awards
Sep. 30, 2012
SARs - 2012 Awards
Jun. 30, 2013
Minimum
SARs - 2012 Awards
Commitments and Contingencies                                      
Performance period     5 years                                
Amount of cash flow performance goals     $ 850.0                                
Amount of cash flow achieved   319.2                                  
Amount of cash flow expenses accrued   4.0                                  
Additional expense expected to be recognized during the year under the amended performance unit awards 1.4                                    
Compensation expense (credit) 0.7                   (1.0) 1.1 3.9 1.8          
Percentage of performance units vested             50.00% 50.00%                      
Average stock price period       60 days 60 days                       60 days    
Amount recorded for performance unit award grants           9.6     2.2 2.2                  
Grants approved by committee to employees for cash settled stock appreciation rights (in shares)                               0.4   1.0  
Grants approved by committee to employees for cash settled stock appreciation rights that remain outstanding (in shares)                             0.2   0.8    
Amount accrued for awards                             $ 1.0   $ 4.4    
Grant-date stock price (in dollars per share)                               $ 3.81 $ 1.85    
Percentage of stock price on grant date                                     135.00%
Threshold stock price at which SARS will vest (in dollars per share)                                     $ 2.50